Skip to main content
Normal View

Medicinal Products Prices

Dáil Éireann Debate, Wednesday - 14 December 2016

Wednesday, 14 December 2016

Questions (183, 186)

Brendan Griffin

Question:

183. Deputy Brendan Griffin asked the Minister for Health his views on a matter (details supplied) regarding the metabolic condition phenylketonuria; and if he will make a statement on the matter. [40322/16]

View answer

Michael Healy-Rae

Question:

186. Deputy Michael Healy-Rae asked the Minister for Health his views on the case of a person (details supplied) with a medical condition; and if he will make a statement on the matter. [40327/16]

View answer

Written answers

I propose to take Questions Nos. 183 and 186 together.

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.

Top
Share